Announced
Completed
VERONA PHARMA PLC / VIVO CAPITAL LLC / NOVO A/S / Acquisition / Acquisition / Public / £6m
Synopsis
PIPE investment by Novo and Vivo Capital in Verona Pharma, a developer of therapeutic drug treatments for hay fever and other chronic respiratory and inflammatory diseases.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.